Back
Virtus AllianzGI Diversified Income & Convertible Fund Vs. Neurogene Industry Stock Comparison
Sell
42
ACV
Virtus AllianzGI Diversified Income & Convertible Fund
Last Price:
20.81
Seasonality Move:
5.52%
Buy
75
NGNE
Neurogene
Last Price:
57.80
Seasonality Move:
58.98%
Sell
42
Virtus AllianzGI Diversified Income & Convertible Fund (ACV)
is a Sell
Is Virtus AllianzGI Diversified Income & Convertible Fund a Buy, Sell or Hold?
- The current Virtus AllianzGI Diversified Income & Convertible Fund [ACV] share price is $20.68. The Score for ACV is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- ACV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Neurogene (NGNE)
is a Buy
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $66.00. The Score for NGNE is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- NGNE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACV Stock Price Chart
What is Virtus AllianzGI Diversified Income & Convertible Fund's stock price today?
-
The Virtus AllianzGI Diversified Income & Convertible Fund share price today is $20.68
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACV is experiencing slight selling pressure.
NGNE Stock Price Chart
ACV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.16 | Sell |
Relative Strength Index (14 RSI): | 31.82 | Sell |
Chaikin Money Flow: | -2087 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.91 - 21.61) | Sell |
Bollinger Bands (100): | (20.65 - 21.39) | Sell |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.06 | Buy |
Relative Strength Index (14 RSI): | 75.97 | Buy |
Chaikin Money Flow: | 176225 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.28 - 53.36) | Buy |
Bollinger Bands (100): | (34.64 - 46.72) | Buy |
ACV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.84 | Sell |
20-day SMA: | 21.27 | Sell |
50-day SMA: | 21.22 | Sell |
200-day SMA: | 21.79 | Sell |
8-day EMA: | 20.85 | Sell |
20-day EMA: | 21.09 | Sell |
50-day EMA: | 21.16 | Sell |
200-day EMA: | 21.22 | Sell |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.43 | Buy |
20-day SMA: | 49.56 | Buy |
50-day SMA: | 43.32 | Buy |
200-day SMA: | 37.93 | Buy |
8-day EMA: | 50.65 | Buy |
20-day EMA: | 48.54 | Buy |
50-day EMA: | 44.96 | Buy |
200-day EMA: | 36.96 | Buy |
Virtus AllianzGI Diversified Income & Convertible Fund Earnings Growth & ACV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.11 per share.
Virtus AllianzGI Diversified Income & Convertible Fund Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |